Skip to content
★ Sign in to follow
OS

Ourofino S.A. Stock: price and insider trades · Brazil

BR·Mcap R$1.5BHealth Care

Ourofino S.A.: what insiders have been doing

Headquartered in Brazil, Ourofino S.A. belongs to the Health Care sector and traces its origins to 1987. Filings by its managers are published through CVM (Brazil). Ourofino S.A. has had no insider filing for more than a year; the last one goes back to 8 January 2024.

Our records for Ourofino S.A. go back to 2020, with 5 purchases and 1 sale on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from CVM (Brazil) disclosures alone and does not predict where the share price will go.

Key facts

Headquarters: Brazil · Founded: 1987

Source: Wikidata (CC0).

Insider Decl.
6
Thresholds
n/a
Buy Volume
€1M
5 ops. · all time
Sell Volume
€54,259
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 2,165 of 26,897 companies
75.9
score / 100
Value
75
Quality
77
FCF yld3.4%
Earn yld14%
EV/EBITDA7.0x
ROE32%
Gross mgn52%
Net mgn18%
Debt/EBITDA1.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

R$28.53
Analyst consensus
1 analysts
·
R$24.00Target R$24.00(-16%)R$24.00
Income statement
RevenueR$1.2B
Gross profitR$633M52% margin
EBITDAR$290.5M24% margin
Net incomeR$222.3M17.3% margin
Valuation
PER (trailing)6.5x
P/Book1.9x
Beta0.29
Balance sheet & cash
Market capR$1.5B
Total debtR$503.6M
Free Cash FlowR$52.6M
Debt / Equity63%
Profitability & ownership
ROE31.8%
ROA12.0%
% insiders86.2%
% institutions8.3%
Last declaration on 8 January 2024
Declarations6 total
  • ▲
    Controlador ou VinculadoExecutives
    7M BRL13CVM
    235,700 shares@ R$30.000.55% mcap96.1% of flowAçõesB3CVM:20258278-90afe91f37dd6f2b
    Canonical exit: 26 Mar 2024 (T+90)
  • ▼
    Controlador ou VinculadoExecutives
    316,748 BRL5CVM
    9,500 shares@ R$33.34190.023% mcap3.9% of flowAçõesB3CVM:20258278-67ea40851567c9f5
  • ▲
    Controlador ou VinculadoExecutives
    70,182 BRL5CVM
    2,500 shares@ R$28.07280.8% of flowAçõesB3CVM:20258278-67bd9ae8fd750cc7
    Canonical exit: 1 Dec 2020 (T+90)
  • ▲
    Controlador ou VinculadoExecutives(filed)
    85,590 BRL5CVM
    3,000 shares@ R$28.531.0% of flowAçõesB3CVM:20258278-2624bf74922aade2
    Canonical exit: 30 Nov 2020 (T+90)
  • ▲
    Controlador ou VinculadoExecutives(filed)
    49,120 BRL5CVM
    1,700 shares@ R$28.89410.5% of flowAçõesB3CVM:20258278-bb613a256126a202
    Canonical exit: 30 Nov 2020 (T+90)
  • ▲
    Controlador ou VinculadoExecutives(filed)
    67,083 BRL5CVM
    2,300 shares@ R$29.16650.7% of flowAçõesB3CVM:20258278-f71974f4d1ce7a8f
    Canonical exit: 30 Nov 2020 (T+90)

6 of 6 declarations

About Ourofino S.A.

Ourofino S.A. is a Brazilian company specializing in the health and pharmaceutical sector. It is listed on the São Paulo Stock Exchange (BVMF).

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations